Powerful genetic and other biological influences influence susceptibility to metabolic disorders such as obesity, type 2 diabetes and dyslipidemia. Many recent advances in understanding the complex pathophysiology of metabolic diseases have resulted from the development and application of a whole repertoire of so-called ‘omics’ technologies.

At our second conference on metabolic disease, global leaders in the field will provide updates on genomics, epigenomics, transcriptomics, proteomics, metabolomics and lipidomics.

The programme will include podium presentations selected from abstracts submitted on the broad themes of the conference. Posters and poster-pitch talks will provide opportunities to present research findings or get feedback on ongoing projects.

This lively meeting aims to improve inter-disciplinary knowledge-dissemination between scientists and clinicians working in basic and therapeutic research. There will be plenty of opportunities to establish collaborations through face-to-face networking with inclusive meals.

Image copyright © Polygraph Design / BIH@Charité